Impact Evaluation of Personalized Oral Hygiene Education on Periodontal Patients Stage I/II/III
NCT ID: NCT04745598
Last Updated: 2021-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2021-03-31
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Evaluation of personalized oral hygiene education on clinical attachment level in periodontal patients stage I/II/III.
Evaluation of personalized oral hygiene education on the psychological determinants described by the Health Action Process Approach (HAPA) and the mediating role of these psychological determinants in oral hygiene habits and clinical parameters in periodontal patients stage I/II/III.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraoral Scanners as a Motivation Method for Oral Hygiene Instruction
NCT05079204
Effectiveness of Medical Coaching in Enhancing Periodontal Health and Lifestyle
NCT06887946
Effectiveness of an Oral Health Literacy Intervention on Oral Health Behaviors and Plaque Index in Orthodontic Patients
NCT06666374
The Impact of Simple Home-based Differential Learning on Oral Hygiene in Children.
NCT04905784
Effectiveness of Personalized Oral Hygiene Education in Medical and Dental Students Over Two Years
NCT07085013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group: Dental model
Patients diagnosed with periodontal disease stage I/II/III
Control group: Dental Model
\- Patients receive a demonstration of plaque control methods (modified Bass dental brushing technique and the use of the electric toothbrush) using a dental model.
Computer-assisted teaching format group
Patients diagnosed with periodontal disease stage I/II/III
Computer-assisted teaching format group
\- Patients receive a Powerpoint presentation containing:
Plaque-disclosing group
Patients diagnosed with periodontal disease stage I/II/III
Plaque-disclosing group
\- Patients place a few drops of a plaque-disclosing solution on the tongue and run the tongue over all the teeth and gums. With the aid of a hand mirror, patients can observe the stained plaque residue on their teeth
Intra-oral Camera group
Patients diagnosed with periodontal disease stage I/II/III
Intra-oral camera group
\- An ACTEON Soprocare® intraoral camera is used during the examination and explanation of oral hygiene strategies.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control group: Dental Model
\- Patients receive a demonstration of plaque control methods (modified Bass dental brushing technique and the use of the electric toothbrush) using a dental model.
Computer-assisted teaching format group
\- Patients receive a Powerpoint presentation containing:
Plaque-disclosing group
\- Patients place a few drops of a plaque-disclosing solution on the tongue and run the tongue over all the teeth and gums. With the aid of a hand mirror, patients can observe the stained plaque residue on their teeth
Intra-oral camera group
\- An ACTEON Soprocare® intraoral camera is used during the examination and explanation of oral hygiene strategies.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject having signed an informed consent
* Subjects with periodontal disease Stage I/II/III :
* ≥ 15 teeth/implants
* Bleeding index at ≥ 25%
* Plaque index ≥ 20%
* Not requiring antibiotic prophylaxis prior to periodontal treatment.
* Not having received surgical periodontal treatment in the last 12 months.
* Smokers of ≤10 cigarettes/day
Exclusion Criteria
* Physical or mental disability that does not allow for the performance of oral hygiene procedures.
* Chronic progressive pathology (diabetes...) / immunodeficiencies (HIV...)/ systemic infections.
* Ongoing drug treatment leading to a significant change in the periodontal condition (anti-epileptics, calcium antagonists, immunosuppressants, hormonal treatments, etc.).
* Ongoing drug treatment that can influence the periodontal condition (anti-inflammatory drugs, antibiotics)
* Patients with severe xerostomia or with Gougerot-Sjögren's syndrome.
* Subjects undergoing treatment for cancer
* Pregnant or breastfeeding women
* Smokers of \> 10 cigarettes/day
* Impossibility to give information about the subject (subject in an emergency situation, difficulties in understanding the French language, etc.).
* Subject under safeguard of justice
* Subject under guardianship or curatorship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.